A multivalent mRNA-LNP vaccine protects against <i>Clostridioides difficile</i> infection

Mohamad‐Gabriel Alameh(Children's Hospital of Philadelphia), Joseph P. Zackular(Children's Hospital of Philadelphia), Robert H. Mach(Washington University in St. Louis), Ceylan Tanes(Children's Hospital of Philadelphia), Paula C. Rangel(Children's Hospital of Philadelphia), Gabrielle S. Blizard(University of Pennsylvania), Jeffrey R. Maslanka(University of Pennsylvania), James J. Knox(University of Pennsylvania), Paul J. Planet(Children's Hospital of Philadelphia), Benjamin Davis(University of Pennsylvania), Emma E. Furth(Hospital of the University of Pennsylvania), Garima Dwivedi(Massachusetts Institute of Technology), Nile U. Bayard(Children's Hospital of Philadelphia), Mark A. Sellmyer(University of Pennsylvania), Ying K. Tam(Arbutus Biopharma (Canada)), Ahmed M. Moustafa(Children's Hospital of Philadelphia), Kyle Bittinger(University of Pennsylvania), Anik Chevrier(Polytechnique Montréal), Drew Weissman(California University of Pennsylvania), Houping Ni(Acuitas Therapeutics (Canada)), Mitchell Beattie(Acuitas Therapeutics (Canada)), Alexa Semon(Children's Hospital of Philadelphia), Yi‐Gen Pan(University of Pennsylvania), Michael C. Abt(Memorial Sloan Kettering Cancer Center), Haitao Hu(Zhejiang Normal University), Rochelle C. Glover(University of Washington), Qianxuan She(Children's Hospital of Philadelphia), Srinivasa Reddy Bonam(Centre National de la Recherche Scientifique), Marc Lavertu(Polytechnique Montréal)

Science

October 3, 2024

Cited by 73

|Nature Biotechnology|2019|23.9k

|Science|2011|6.6k

|Nature Reviews Drug Discovery|2018|4.4k

|Nature Biotechnology|2010|1.8k

|Nature Nanotechnology|2019|1.6k

Related Papers